AMUND — Almunda Professionals NV Share News
0.000.00%
Last trade - 00:00- €27.60m
- €39.63m
- €31.40m
Brief: Novisource announces nomination of Bram Schot as new CFO
Brief: Cesca Therapeutics qtrly loss per share $0.11
Brief: Cesca Therapeutics announces approval of its Marrowxpress system in India
Brief: Cesca gets FDA feedback device to treat critical limb ischemia
Brief: Kenneth Harris recommends a Cesca independent director
Brief: Cesca Therapeutics files U.S. pivotal ide application
Brief: Cesca Therapeutics Q1 revenue $3.7 mln
Brief: Cesca Therapeutics says Robin Stracey to serve as interim CEO
Brief: Mitchel Sivilotti reports 11.5 percent stake in Cesca Therapeutics